We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
876
Lear
LEA
$8.16B
$2.9M 0.01%
25,342
-2,007
-7% -$214K
AM icon
877
Antero Midstream
AM
$10.5B
$2.9M 0.01%
162,922
-9,228
-5% -$166K
CF icon
878
CF Industries
CF
$17.7B
$2.9M 0.01%
37,473
-2,699
-7% -$222K
BMI icon
879
Badger Meter
BMI
$3.78B
$2.9M 0.01%
16,604
-779
-4% -$140K
AIZ icon
880
Assurant
AIZ
$13.9B
$2.89M 0.01%
12,015
-506
-4% -$113K
BG icon
881
Bunge Global
BG
$21.7B
$2.89M 0.01%
32,432
-2,222
-6% -$205K
UHS icon
882
Universal Health Services
UHS
$10.1B
$2.88M 0.01%
13,212
-743
-5% -$164K
MMSI icon
883
Merit Medical Systems
MMSI
$5.4B
$2.88M 0.01%
32,678
-1,573
-5% -$134K
ACA icon
884
Arcosa
ACA
$7.12B
$2.88M 0.01%
27,075
-1,300
-5% -$131K
RLI icon
885
RLI Corp
RLI
$5.87B
$2.87M 0.01%
44,920
-2,316
-5% -$145K
HXL icon
886
Hexcel
HXL
$7.74B
$2.87M 0.01%
38,889
-1,996
-5% -$141K
JHG
887
DELISTED
Janus Henderson
JHG
$2.87M 0.01%
60,395
-3,732
-6% -$165K
APPF icon
888
AppFolio
APPF
$7.22B
$2.87M 0.01%
12,317
-465
-4% -$111K
COMP icon
889
Compass
COMP
$10.2B
$2.86M 0.01%
270,891
-2,123
-0.8% -$19.4K
HLNE icon
890
Hamilton Lane
HLNE
$5.91B
$2.85M 0.01%
21,245
-773
-4% -$97.2K
MC icon
891
Moelis & Co
MC
$5.21B
$2.85M 0.01%
41,493
-2,097
-5% -$140K
ROAD icon
892
Construction Partners
ROAD
$6.73B
$2.85M 0.01%
26,236
-1,265
-5% -$142K
PTGX icon
893
Protagonist Therapeutics
PTGX
$9.8B
$2.83M 0.01%
32,440
-1,406
-4% -$115K
GAP
894
The Gap Inc
GAP
$7.34B
$2.83M 0.01%
110,601
-6,406
-5% -$155K
ESE icon
895
ESCO Technologies
ESE
$7.79B
$2.82M 0.01%
14,416
-804
-5% -$169K
BCPC
896
Balchem Corp
BCPC
$5.65B
$2.82M 0.01%
18,363
-895
-5% -$137K
GVA icon
897
Granite Construction
GVA
$5.41B
$2.81M 0.01%
24,390
-1,267
-5% -$136K
DAR icon
898
Darling Ingredients
DAR
$10.4B
$2.81M 0.01%
78,109
-3,993
-5% -$135K
ULS icon
899
UL Solutions
ULS
$15.5B
$2.8M 0.01%
+35,539
New +$2.85M
SOLV icon
900
Solventum
SOLV
$14.7B
$2.8M 0.01%
35,343
-1,226
-3% -$93.9K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.